Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

ProQR Therapeutics N.V (PRQR) Equity Average: 2021-2022

Historic Equity Average for ProQR Therapeutics N.V (PRQR) over the last 1 years, with Mar 2022 value amounting to $107.3 million.

  • ProQR Therapeutics N.V's Equity Average was N/A to $107.3 million in Q1 2022 from the same period last year, while for Mar 2022 it was $107.3 million, marking a year-over-year change of. This contributed to the annual value of $69.7 million for FY2024, which is 23.58% up from last year.
  • Per ProQR Therapeutics N.V's latest filing, its Equity Average stood at $107.3 million for Q1 2022, which was down 1.95% from $109.4 million recorded in Q4 2021.
  • In the past 5 years, ProQR Therapeutics N.V's Equity Average ranged from a high of $109.4 million in Q4 2021 and a low of $75.7 million during Q2 2021.
  • Moreover, its 2-year median value for Equity Average was $97.0 million (2022), whereas its average is $94.8 million.